URIST MARSHALL (EVP & Co-Head Research & Inv.) received a stock award from ROYALTY PHARMA PLC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 11/7/2025ACC: 0001838139-25-000004
Officer· EVP & Co-Head Research & Inv.
Since Dec 2020
+148.63K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
164.63K acquired · 16K disposed
Non-Derivative Transactions2
Class A Ordinary Shares
Direct
Shares
+4.63K
Price / share
—
Trade value
—
% of position
11.8%
11/5/2025
39.26K→43.88K
Class A Ordinary Shares
Indirect
Shares
+160K
Price / share
—
Trade value
—
% of position
342.9%
11/7/2025
46.67K→206.67K
Total
Net shares
+164.63K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Ordinary Shares Direct | 11/5/2025 | A · Award | +4.63K | — | — | 11.8% | 39.26K | 43.88K |
| Class A Ordinary Shares Indirect | 11/7/2025 | C · Conversion | +160K | — | — | 342.9% | 46.67K | 206.67K |
| Total | +164.63K | $0.00 | ||||||
Derivative Transactions1
LP interests in RPI US Partners 2019, LP
Indirect
Converts to
Class A Ordinary Shares
160K shares
Shares
−16K
Strike price
0
Held after
247.41K
Exercisable
—
11/7/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| LP interests in RPI US Partners 2019, LP Indirect | Class A Ordinary Shares160K shares | 11/7/2025 | C · Conversion | −16K | 0 | — | 247.41K |
Non-Derivative Holdings (Post-Transaction)1
Class A Ordinary Shares
IndirectShares owned19.02K
Total
19.02K indirect19.02K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Class A Ordinary Shares | 19.02K | Indirect |
| Total | 19.02K | 19.02K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported